Cipla rallies nearly 3% on getting US patent for stemcell product – Economic Times
|
Cipla rallies nearly 3% on getting US patent for stemcell product
Economic Times NEW DELHI: Cipla Ltd rallied as much as 2.7 per cent in trade on Thursday, after Stempeutics Research received a process patent from the United States Patent and Trademarks Office for its novel stem cell-based drug Stempeucel, said media reports. Cipla’s Stempeutics gets US patent for stemcell productHindu Business Line Stempeutics Receives US Process Patent for Its Novel Stem Cell Drug …GlobeNewswire (press release) Stempeutics receives US process patent for novel stem cell drug StempeucelMyiris.com |
|
Cipla rallies nearly 3% on getting US patent for stemcell product
Economic Times NEW DELHI: Cipla Ltd rallied as much as 2.7 per cent in trade on Thursday, after Stempeutics Research received a process patent from the United States Patent and Trademarks Office for its novel stem cell-based drug Stempeucel, said media reports. Cipla’s Stempeutics gets US patent for stemcell productHindu Business Line Stempeutics Receives US Process Patent for Its Novel Stem Cell Drug …GlobeNewswire (press release) Stempeutics receives US process patent for novel stem cell drug StempeucelMyiris.com |
|
‘He Stole My Heart’: Stem Cell Therapy May Help Pup Walk (Video)
Patch.com Because Bolt’s spinal cord wasn’t completely severed, Kelley thinks Bolt can recover the use of his lower half with stem cell treatment. He has been in contact with a stem cell research center in Kentucky to get the dog approved for in-house treatment. |
|
‘He Stole My Heart’: Stem Cell Therapy May Help Pup Walk (Video)
Patch.com Because Bolt’s spinal cord wasn’t completely severed, Kelley thinks Bolt can recover the use of his lower half with stem cell treatment. He has been in contact with a stem cell research center in Kentucky to get the dog approved for in-house treatment. |